Taiwan-based vaccine maker Medigen will conduct a Phase 3 clinical trial for its COVID-19 vaccine in Europe once it has received approval from European authorities, which would help pave the way for its entry into European and other international markets, the company announced Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Han Kuang: Army choppers practice hot-pit refueling in New Taipei, Taichung
07/17/2025 02:47 PM - Business
Taiwan shares close up 0.31%
07/17/2025 01:48 PM - Business
Wistron to expand AI server output via California unit
07/17/2025 01:08 PM - Sports
Taiwan fencer, tennis player lead team at Universiade opening
07/17/2025 12:12 PM - Politics
Pope Leo XIV offers prayers for Taiwan over Typhoon Danas casualties, damage
07/17/2025 12:01 PM